Skip to main content
Clinical Trials/JPRN-UMIN000037967
JPRN-UMIN000037967Completed未知

A multicenter prospective observational study of atezolizumab plus bevacizumab plus carboplatin plus paclitaxel (ABCP) in patients with unresectable advanced or relapsed EGFR-mutation positive nonsquamous non-small-cell lung cancer: ABCP observational study - ABCP multicenter prospective observational study

Department of Thoracic Oncology, Kansai Medical University Hospital0 sites142 target enrollmentStarted: September 10, 2019Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
142

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • A Patient who is judged ineligible to enroll the study by an attending doctor.

Investigators

Sponsor
Department of Thoracic Oncology, Kansai Medical University Hospital

Similar Trials